These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7659993)

  • 1. [Myelocytosis in adults. Diagnostic orientation].
    Bernard P
    Rev Prat; 1995 Jun; 45(11):1413-6. PubMed ID: 7659993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelocytosis in adults. Diagnostic orientation].
    Guilhot F
    Rev Prat; 1992 Apr; 42(7):913-4. PubMed ID: 1604216
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia.
    Stenke L; Näsman-Glaser B; Edenius C; Samuelsson J; Palmblad J; Lindgren JA
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():883-6. PubMed ID: 1825431
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
    Richebourg S; Theisen O; Plantier I; Parry A; Soenen-Cornu V; Lepelley P; Preudhomme C; Renneville A; Laï JL; Roche-Lestienne C
    Genes Chromosomes Cancer; 2008 Oct; 47(10):915-8. PubMed ID: 18615682
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular diagnosis of myeloproliferative neoplasms.
    Patnaik MM; Tefferi A
    Expert Rev Mol Diagn; 2009 Jul; 9(5):481-92. PubMed ID: 19580432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neutrophil function in hematologic disorders].
    Matzner Y
    Harefuah; 1991 Dec; 121(11):449-52. PubMed ID: 1786895
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of molecular haematology: an overview.
    Bain BJ
    J Assoc Physicians India; 2007 Jul; 55():503-6. PubMed ID: 17907501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte dysfunction in hematological disorders.
    Matzner Y
    Cancer Invest; 1992; 10(2):155-61. PubMed ID: 1551025
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J; Kvasnicka HM
    Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical chronic myeloid leukemias.
    Oscier D
    Pathol Biol (Paris); 1997 Sep; 45(7):587-93. PubMed ID: 9404484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of the myeloproliferative disorders: resolving phenotypic mimicry.
    Spivak JL
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):1-5. PubMed ID: 12682874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
    Nakata Y
    Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
    Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC
    Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
    Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
    Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
    Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
    Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.